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Summary Aspects of sexuality were assessed by questionnaires in 76 testicular cancer patients after orchiec-
tomy before further treatment and, respectively, 6, 12 and 36 months after therapy. Before treatment 11% of
the patients reported dissatisfaction with sexual life. About 20% of the patients sometimes experienced reduced
libido and erectile difficulties. Six months after therapy significantly more patients (27%) recorded an
unsatisfactory sexual life as compared to the pretreatment situation. At the 36 months' evaluation 22 of 76
evaluable patients (18%) still stated that their sexual life was inferior to the pretreatment experience. Libido
and erectile function decreased transiently during the first year after treatment in most patients. Twelve
patients reported permanent 'dry ejaculation' after bilateral retroperitoneal lymph node dissection. Other
sexual disturbances could not be related to specified treatment modalities. Increased age at the time of
diagnosis and psychological distress tended to correlate with the incidence of sexual problems. For about 60%
of the patients the discussion of expected and experienced sexual life problems was an important issue to be
discussed before their treatment for testicular cancer and during follow-up. The high frequency of any kind of
long-lasting sexual problems (30%), though often of minor degree, warrants an adequate counselling of these
patients before and after treatment.
Recent investigations have shown post-treatment distur-
bances of sexual life in 20-50% of testicular cancer patients
(Rieker et al., 1985; Schover & von Eschenbach, 1985;
Schover et al., 1986; Moynihan, 1987; Nijman et al., 1988;
Stoter et al., 1989). Most studies have been done retrospec-
tively. The aim of the present study was to prospectively
evaluate concerns in regard to sexual life in an unselected
group of testicular cancer patients at the time of diagnosis
and during a 3 years' post-treatment follow-up.
Patients and methods
From 1st November 1985 to 31st October 1986 89 consecu-
tive patients with newly diagnosed testicular cancer were
included in a prospective study dealing with somatic side
effects and psycho-social problems. The present paper mainly
deals with the aspects of sexuality. Thirteen patients were
excluded from the final analysis (mental retardation: three
patients; major deviation from treatment protocol: one
patient; relapse: three patients; death of intercurrent disease:
three patients; lack of follow-up compliance: three patients),
thus leaving 76 patients. Both patients with seminoma (41)
and non-seminoma (35) were included in the study (Table I).
The median age at the time of orchiectomy for the patients
was 31.2 years (range 16.5-71.9). Staging was performed
according to The Royal Marsden Staging System (Horwich
et al., 1989). Patients treated with all modalities were
included. The treatment principles have been outlined else-
where (Aass et al., 1990). Thirteen patients underwent uni-
lateral retroperitoneal lymph node dissection (RLND) as
their only treatment after orchiectomy. Thirty-six patients
received only abdominal radiotherapy. Four patients received
both cisplatin-based chemotherapy and abdominal irradia-
tion. Finally, 23 patients were treated with cisplatin-based
combination chemotherapy followed by uni- or bilateral
RLND.
The evaluation of sexuality was based on information from
self-administered questionnaires completed by the patients
after orchiectomy and before start offurther therapy (median
0.6 months after orchiectomy, range 0.03-2.7 months), and,
respectively, 6, 12 and 36 months after treatment discon-
tinuation. At the first evaluation the patients were asked
about their sexual life in general before the malignant disease
was diagnosed. At every post-treatment assessment they were
asked about their present sexual life without specifying the
exact time span that pertained to these questions. On one
hand the questions addressed 'functional' aspects of sexual
life as erection and ejaculation, and, on the other hand, the
patients' evaluation of sexual satisfaction, libido and impor-
tance of sexual questions for overall well-being. In addition
to the domain of sexuality the questionnaire covered ques-
tions regarding anxiety, nervousness and depression, as used
in retrospective series performed by our group (Kaasa et al.,
1991).
Statistics
The PC-based statistical program 'Medlog' was used to cal-
culate means, medians and ranges and to compare distribu-
tions with each other (Wilcoxon test). A P-value less than
0.05 was regarded as statistically significant.
Table I Patient and treatment characteristics
No. ofpatients
Histology
Seminoma 41
Non-seminoma 35
Stage
I 46
II 25
III
IV 4
RLNDa
Unilat.
Bilat.
Cisplatin-based chemotherapy
< 3 cycles
4 cycles
>4 cycles
Abdominal radiotherapy
21
15
27
10
15
2
40
aRetroperitoneal lymph node dissection.
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Results
Forty-five, 36, 39 and 49 patients stated that it was important
for them to discuss sexual problems with their physician
before and 6, 12 and 36 months post-treatment, respectively
(Table Ha). As expected the percentage of patients interested
in sexual problems was lowest at the first post-treatment
evaluation, especially for the patients who were more than 40
years at the time of orchiectomy.
Sixty-two per cent of the patients stated at the time of
diagnosis that sexuality was of importance to them without
difference comparing men 40 years old or younger with those
over 40. This figure was largely unchanged at the post-
treatment assessments.
At the time of diagnosis eight (11%) of 73 patients, res-
ponding to this question, indicated an unsatisfactory sexual
life. Six months after treatment discontinuation this figure
had increased to 20 of 73 patients (27%, P = 0.02). However,
after 12 and 36 months, respectively, the percentage of
patients with an unsatisfactory sexual life was only slightly
higher than before treatment (P = 0.3).
At every post-treatment evaluation the majority of patients
who reported unsatisfactory sexual life also stated that their
present sexual life was inferior to the pretreatment experience.
The occurrence of serious anxiety, nervousness, depression
and loneliness was generally low at each time of evaluation
(Table III). There was a tendency that patients reporting
psychological distress more often evaluated their sexual life
as unsatisfactory, but the numbers are too small to draw any
firm conclusions.
At the time ofdiagnosis 12 patients feared that their sexual
life would become worse after therapy, whereas 64 patients
did not express this anxiety. Three years post-treatment four
of the former 12 patients and 18 of the 64 patients answered
that their present sexual life was inferior to the pretreatment
experience (P = 0.77) (Table IV). Six of these 22 patients,
nevertheless, described their sexual life as satisfactory. Before
treatment as many as 17 of these 22 patients stated that they
had a satisfactory sexual life. Erectile difficulties, dry ejacula-
tion and reduced libido were the disturbances which most
often had developed within 3 years after therapy. The median
age of the 22 patients at the time of orchiectomy was about 3
Table Ila Items concerning sexuality: psychological aspects
Pre- Post-treatment
treatment 6 months 12 months 36 months
Time from orchiectomy to answering questionnaire 0.6a 8.9 15.2 39.6
(months) 0.03-2.7b 7.0-14.6 12.9-19.9 37.1 -45.6
No. of married/cohabitant individuals 57 (75)C 56 (74) 54 (73) 57 (75)
Importance of discussing sexual problems
Very important/importantd 45 (61) 36 (49) 39 (55) 49 (65)
Less important/unimportant 21 (28) 28 (39) 25 (35) 23 (31)
Ambiguous 8 9 7 3
Importance of sexual life
Very important/importante 45 (62) 39 (53) 41 (59) 47 (64)
Less important/unimportant 25 (34) 29 (40) 28 (40) 26 (35)
Ambiguous 3 5 1
Expectation of future sexual life
As before 42 (58)
Worse 12 (16)
Ambiguous 19
Evaluation of present sexual life
As before 41 (56) 49 (69) 48 (67)
Worse 28 (38) 18 (25) 22 (31)
Ambiguous 4 4 2
Satisfactory sexual life?
Yes' 54 (74) 43 (59) 49 (68) 48 (67)
No 8 (11) 20 (27) 13 (18) 13 (18)
Ambiguous 11 10 10 10
Reduced libido?
Yesg 3 (4) 17 (24) 9 (13) 7 (10)
No 70 (96) 55 (76) 58 (87) 61 (90)
aMedian; bRange; cPercentage of answered questions; dP-values at 6, 12 and 36 months 0.16, 0.47 and 0.57,
respectively, compared to pretreatment results; ePP-values at 6, 12 and 36 months 0.32, 0.71 and 0.73, respectively,
compared to pretreatment results; `P-values at 6, 12 and 36 months 0.02, 0.33 and 0.31, respectively, compared to
pretreatment results; 9P-values at 6, 12 and 36 months 0.0008, 0.07 and 0.20, respectively, compared to pretreatment
results. The total number ofalternatives may be less than the total number ofpatients due to lack ofanswers to single
questions.
Table IIb Items concerning sexuality: 'functional' aspects
Pre- Post-treatment
treatment 6 months 12 months 36 months
Erectile difficulties?
Neverb 58 (79)a 43 (59) 46 (65) 49 (65)
Seldom/Sometimes 15 (21) 27 (37) 24 (34) 22 (29)
Often/Always - 3 1 2
Ambiguous - - - -
'Dry ejaculation'?
Neverc 60 (82) 44 (62) 41 (60) 44 (62)
Seldom/Sometimes 13 (18) 14 (20) 16 (23) 14 (20)
Often/Always - 13 (18) 12 (17) 12 (17)
Ambiguous - - I
aPercentageofansweredquestions; bP-values at6, 12and36months0.007,0.009 and0.09,respectively, compared to
pretreatment results; cP-values at 6, 12 and 36 months 0.007, 0.003 and 0.01, respectively, compared to pretreatment
results. The total number ofalternatives may be less than the total numberofpatients due to lack ofanswers to single
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Table III Psychological distress and dissatisfaction with sexual life
Pre- Post-treatment
treatment 6 months 12 months 36 months
Anxious, nervous
Neverb 36 (4)- 47 (10) 44 (5) 47 (3)
Sometimes 30 (3) 24 (7) 28 (7) 23 (6)
Often 8 (1) 4 (3) 1 (1) 4 (3)
Depressed
Neverc 47 (3) 54 (13) 51 (7) 49 (5)
Sometimes 23 (4) 19 (5) 20 (5) 22 (6)
Often 4 (1) 3 (2) 2 (1) 4 (2)
Lonely
Never" 38 (3) 46 (9) 44 (6) 41 (4)
Seldom/Sometimes 37 (5) 28 (9) 28 (6) 34 (9)
Often/Very often - 2 (2) 2 (1) 1 (0)
aNumber ofpatients reporting unsatisfactory sexual life; bP-values at 6, 12
and 36 months 0.09, 0.16 and 0.07, respectively, compared to pretreatment
results; cP-values at 6, 12 and 36 months 0.32, 0.41 and 0.82, respectively,
compared to pretreatment results; dP-values at 6, 12 and 36 months 0.22, 0.28
and 0.69, respectively, compared to pretreatment results. The total number of
alternativesmaybelessthanthetotal numberofpatientsduetolackofanswers
to single questions.
Table IV Sexual life before treatment and 3 years afterwards in 22 patients with
post-treatment deterioration of sexual life
36 months
Pretreatment post-treatment
Age at orchiectomy 34.9a
18.3-71.8b
Married/cohabitant 17 16
Treatment
RLNDC unilat. only 3
Abdominal radiotherapy only 11
Chemotherapy + RLND unilat. 2
Chemotherapy + RLND bilat. 5
Chemotherapy + abd. radioth. I
Satisfactory sexual life?
Yes 17 (77)d 6 (29)
No 2 12
Ambiguous 3 3
Reduced libido?
Yes 2 7
No 19 (90) 10 (59)
Erectile difficulties?
Never 16 (76) 8 (38)
Seldom/Sometimes 5 (24) 11 (52)
Often/Always - 2
Ambiguous
'Dry ejaculation'?
Never 15 (71) 11 (52)
Seldom/Sometimes 6 (29) 5 (24)
Often/Always - 5 (24)
Ambiguous
aMedian; bRange; cRetroperitoneal lymph node dissection; dPercentage of answered
questions. The total number ofalternatives may be less than the total number ofpatients
due to lack of answers to single questions.
years higher than for the whole patient population. Eleven of
them had received abdominal radiotherapy as their only
treatment and seven were treated with both chemotherapy
and RLND. Anxiety, nervousness and depression were not
reported more frequently by the 22 patients than by the
whole patient population.
Before treatment three patients (4%) stated that they had
reduced libido. At the evaluation 6 months after therapy the
comparable figure had risen significantly to 17 (24%) (P =
0.0008). Twelve and 36 months post-treatment the percentage
of patients with reduced libido was 13% and 10%, respec-
tively (P = 0.07 and P = 0.20, respectively).
Erectile difficulties were recorded significantly more often 6
and 12 months after treatment discontinuation (41% and
35%, respectively) as compared to the evaluation at the time
of diagnosis (21%) (P = 0.007 and P = 0.009, respectively)
(Table HIb). At the last evaluation no significant difference was
found for the whole patient population compared to the
pretreatment situation (P = 0.09). However, after treatment
more patients above the age of 40 years at the time of
diagnosis reported erectile problems as compared to the
younger individuals (P = 0.01, P = 0.14 and P = 0.05, respec-
tively, at the evaluation 6, 12 and 36 months post-treatment).
At the time of diagnosis 13 patients (18%) stated that they
sometimes or seldom had 'dry ejaculation'. At the pretreat-
ment situation no patients experienced this dysfunction con-
tinuously. At the last evaluation 12 patients (17%), who all
had been operated with bilateral RLND, reported permanent
'dry ejaculation'. Only one of these 12 patients stated that the
experience of 'dry ejaculation' was of no significance for his
sexual life, but only three described their sexual life as
unsatisfactory.
All the questions about sexual life were also analysed
regarding whether or not a patient lived together with a1116 N. AASS et al.
partner. Before treatment 40 of 56 evaluable married or
cohabiting patients stated that sexual life was very important
or important to them as opposed to five of 17 evaluable
single patients (P = 0.004). Significantly more married or
cohabiting patients (45 of 56) evaluated their sexual life as
satisfactory at the time of diagnosis compared to single
patients (nine of 17) (P = 0.05). No other significant differ-
ences were observed at the pretreatment assessment. Three
years after therapy significant differences were only found for
the question regarding satisfaction with sexual life. Forty-one
of 55 evaluable patients living together with a partner were
satisfied with their sexual lives compared to seven of 16
evaluable single patients (P = 0.04).
Discussion
The present study describes sexual life disturbances in a
prospective and unselected series of all patients aged 15 years
and older with newly diagnosed testicular cancer seen at the
Norwegian Radium Hospital during 1 year. No patient refus-
ed to participate in the study when he was admitted to the
hospital for the first time. The percentage of responding
patients in other studies varies from 43-84% (Rieker et al.,
1985; Schover & von Eschenbach, 1985; Schover et al., 1986;
Moynihan, 1987; Gritz et al., 1988; Stoter et al., 1989) and
reservations regarding biased patient selection should be
taken when the results of studies with low patient's response
are interpreted.
A limitation of the present study concerns the question-
naire, which was composed specifically for this study in
1984/85. At that time we were not aware of any validated
questionnaire which extensively addressed items of sexuality
in testicular cancer patients together with psychological issues
as anxiety or depression. We therefore selected relevant ques-
tions and response alternatives from validated questionnaires
used in population-based Norwegian series of healthy indivi-
duals (Eriksen & NMss, 1986; Kiberg, 1988). If a similar study
is to be started today, the use of validated questionnaires is
highly recommended.
In the present investigation we could not define any con-
trol group of Norwegian patients with testicular cancer.
Patients following a surveillance policy (Hoskin et al., 1986)
would have represented such a control group, but this treat-
ment policy was not introduced in Norway before 1987. Due
to the lack of a control group together with the low number
of patients within each treatment modality the present series
represents mainly a descriptive report on sexuality in testic-
ular cancer patients, as opposed to, for example, Rieker et
al.'s (1985; 1989) and Schover and Eschenbach's (1985)
reports. In these series explanatory correlations were done
between treatment and outcome in regard to sexuality and
psychological well-being.
We have tried to differentiate between more 'functional'
disturbances of sexual life ('dry ejaculation', erectile pro-
blems) and psychological aspects (satisfaction, libido), though
a strict differentiation was not always possible. From the
questionnaires it also became clear that the patients' evalua-
tion of 'sexual life' most often described their overall exper-
ience of sexuality combining 'functional' and psychological
aspects.
Our percentage of 33% of the patients reporting some
erectile difficulties 3 years after treatment is higher than in
some of the other comparable studies (Schover & von Eschen-
bach, 1985; Moynihan, 1987; Nijman et al., 1988; Stoter et
al., 1989). This may be due to the fact that we included also
the oldest patients in whom erectile problems seem to occur
more frequently (Schover et al., 1986). Furthermore, our final
response category 'Erectile problems seldom/sometimes'
included also patients with minor problems. Most of them
would probably have answered 'no' if there were only 'yes/
no' alternatives. Our low percentage of permanent erectile
problems (2%) is in accordance with Gritz et al. (1988) who
reported that 6% of their patients regularly suffered from
erectile dysfunction 48 months after treatment discontinua-
tion. No relationship was found between the frequency of
erectile disturbances and the different treatment modalities
contrary to Schover and von Eschenbach's (1985) findings.
These authors reported erectile problems to occur signifi-
cantly more often in patients treated with radiotherapy in
addition to RLND compared to those who had only surgical
treatment.
'Dry ejaculation' was the most often treatment-related
'functional' disturbance of sexual life following retroperi-
toneal lymph node dissection. However, only five of 12
patients with 'dry ejaculation' complained about concomitant
deterioration of their sexual life. This observation is some-
what contradictory to a recent study by Rieker et al. (1989)
who found that ejaculatory dysfunction was significantly
associated with the patients' experience of sexual life impair-
ment.
The incidence of different sexual problems was highest at
the first post-treatment assessment (6 months after treatment
discontinuation). At the 3-year evaluation only 'dry ejacula-
tion' was reported significantly more often than at the time
of diagnosis. The 6 months' maximum of sexual problems is
not unexpected as the patients at the 6 months' evaluation
recently had finished often intensive treatment and also had
been through a psychological crisis. Some of the difficulties
may also be due to reversible alterations of the hormonal
status with an increase of the oestradiol/testosterone ratio
and a rise of sex hormone binding globulin (Fossa & Haug,
1990).
Our observations of gradual reduction of sexual problems
during prolonged post-treatment follow-up are in some con-
trast to the initial results of Rieker et al. (1985) who, with an
observation time of up to 10 years, found that the number of
years elapsed since treatment correlated with the incidence of
impaired sexual function. However, Rieker et al. (1985) did
not follow the same patient population over time, and they
based their suggestion on only one evaluation in each indi-
vidual. In addition, some of the described difference between
our and Rieker et al.'s (1985) observations may be due to
different views on sexual life and life quality in general in a
small European country and in the USA. Schover and her
colleagues (Schover & von Eschenbach, 1985; Schover et al.,
1986), on the other hand, found rate of sexual problems
which are similar to ours when patients were evaluated 5 or
10 years after treatment. Schover et al.'s and our figures are
also more in agreement with Rieker et al.'s observations from
1989 which do not support a correlation with the duration of
the post-treatment period and the incidence of sexual distur-
bances. Differences between the present and other studies
concerning patient selection, applied methods and presenta-
tion of results imply, however, that any comparisons should
be done with caution.
About 30% of the patients (22 patients) in the present
series reported sexual life impairment 3 years after treatment.
Half of them described their sexual life as unsatisfactory.
Apart from a higher median age and a higher incidence of
post-treatment 'dry ejaculation' we have not been able to
identify significant risk factors which at an early phase of the
treatment would identify patients with the highest ability of
post-treatment sexual life impairment.
Most patients considered it of great importance to discuss
aspects of sexual life at the time ofdiagnosis and 18% of the
newly diagnosed patients feared future deterioration of their
sexual life. However, patients are usually too shy to talk
about their sexual problems without being asked specifically.
It is therefore important that the physician initiates the dis-
cussion of these issues as part of the routine information
given to the patient before start of treatment. The patient
should be assured that he most probably will not experience
major permanent problems to his sexual life, though some -
most often transient - difficulties may occur during the first
year. Such a discussion also indirectly emphasises the good
prognosis of the malignancy. Furthermore, problems about
sexuality should also be discussed with the patients at the
follow-up examinations. After treatment discontinuation the
patients must ajust to a 'normal' life situation again includingSEXUAL LIFE IN TESTICULAR CANCER PATIENTS 1117
the domain of sexuality. With professional help this process
of adjustment may be more easy.
Summary and conclusions
(1) Six months after treatment about 40% of the patients
report impaired sexual life with some recovery within
the next 21 years. However, as many as 30% of the
patients record continuous sexual life problems 3 years
after treatment leading to continuous sexual dissatisfac-
tion in half of them.
(2) Except for RLND, implying the risk of 'dry ejaculation'
no correlation was found between sexual life problems
and the treatment modality. Men above the age of 40
years seemed to represent a high-risk group for develop-
ment of post-treatment problems of sexual life.
(3) Sexual problems should be discussed with all patients as
part of the general information before start of treatment
and at follow-up examinations.
The study was financially supported by the Norwegian Cancer
Society.
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